Sheng Nuo Pharmaceuticals - B (02257) plans to issue approximately 17.3524 million shares at a discount of about 19.84%, raising approximately HK$206 million.

Wisdom Financial News APP News, Sinovac Biomedical-B (02257) announced that on September 7, 2025, the company plans to issue 17.3524 million subscription shares to the subscribers (Huaxi Biotechnology (Hong Kong) Co., Ltd., Mr. Xie Shuohao, Bamboo Bloom Limited, Capstone Resources Holding Limited), equivalent to approximately 14.16% of the enlarged issued share capital of the company after the issuance of all subscription shares. The subscription price for each subscription share is HK$12.00, representing a discount of approximately 19.84% compared to the closing price of HK$14.97 per share on September 5.